APA

Bridel C., Eijlers A. J. C., van Wieringen W. N., Koel-Simmelink M., Leurs C. E., Schoonheim M. M., Killestein J. & Teunissen C. E. (2018). No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients. : Frontiers in molecular neuroscience.

Chicago

Bridel Claire, Eijlers Anand J C, van Wieringen Wessel N, Koel-Simmelink Marleen, Leurs Cyra E, Schoonheim Menno M, Killestein Joep and Teunissen Charlotte E. 2018. No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients. : Frontiers in molecular neuroscience.

Harvard

Bridel C., Eijlers A. J. C., van Wieringen W. N., Koel-Simmelink M., Leurs C. E., Schoonheim M. M., Killestein J. and Teunissen C. E. (2018). No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients. : Frontiers in molecular neuroscience.

MLA

Bridel Claire, Eijlers Anand J C, van Wieringen Wessel N, Koel-Simmelink Marleen, Leurs Cyra E, Schoonheim Menno M, Killestein Joep and Teunissen Charlotte E. No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients. : Frontiers in molecular neuroscience. 2018.